Author

Yun Chen

Observed name: Y. Chen

Institutions: Tongji University, Shanghai Pulmonary Hospital

Observed institutions: Tongji University, Xinjiang Medical University, Tumor Hospital of Xinjiang Medical University, Shanghai Pulmonary Hospital

ORCID: 0009-0002-0047-6394

Observed ORCID: 0009-0002-0047-6394

OpenAlex ID: A5023168652

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance

2025 · Yi Chen, Menglin Bai, et al. · Cancer Medicine · 48

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study

2024 · Leilei Wu, Bo Cheng, et al. · MedComm · 22

Effects of Carbon Nanotube-Carbon Fiber Cementitious Conductive Anode for Cathodic Protection of Reinforced Concrete

2016 · J. Zuo, W. Yao, et al. · Journal of Testing and Evaluation · 11

OA08.02 Efficacy and Safety of 1L Olomorasib + Chemoimmunotherapy in KRAS G12C-Mutant NSCLC: Results From LOXO-RAS-20001 and SUNRAY-01

2025 · M.V. Negrao, J.V. Uyeki, et al. · Journal of Thoracic Oncology · 6

Preliminary results of a randomized controlled, open-label, multi-center phase II study of camrelizumab combined with chemotherapy followed by concurrent chemoradiotherapy and camrelizumab consolidation therapy versus standard chemoradiotherapy as first-line treatment for limited-disease small cell lung cancer.

2024 · Xu Yaping, Jian Ni, et al. · Journal of Clinical Oncology · 2

Ferroelectric relaxor properties characterized by dynamic mechanical analysis

2020 · Y. Chen, X. Wang, et al. · Ferroelectrics · 2

Application of a contralateral esophageal-sparing technique to reduce radiation esophagitis in limited-stage small cell lung cancer treated with twice-daily radiotherapy and concurrent chemotherapy.

2023 · Min Hu, Shuangyan Yang, et al. · Journal of Clinical Oncology · 1

Risk Factor Study of Radiation Pneumonitis Focused on Subclinical Interstitial Lung Disease in Definitive Radiation Therapy for Non–Small Cell Lung Cancer: A Single-Institution Experience

2016 · Y. Li, S. Liang, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Precision Stereotactic Body Radiotherapy for Ultra‐Central NSCLC: Tailored Margins Reduce Toxicity Without Compromising Tumor Control

2026 · Di Liu, Shuangyan Yang, et al. · MedComm

Influence of neoadjuvant spatially fractionated stereotactic body radiotherapy on antitumor immunity and pathological response to toripalimab-based immunochemotherapy in resectable stage IIA-IIIB non-small cell lung cancer.

2026 · Xu Yaping, Deping Zhao, et al. · Journal of Clinical Oncology

Effect of hypofractionated radiotherapy plus GM-CSF on antitumor activity with PD-1/PD-L1 inhibitors in oligoprogressive advanced NSCLC: A prospective phase II study.

2026 · Yaping Xu, Chenxue Jiang, et al. · Journal of Clinical Oncology

Balancing tumor control and toxicity: SBRT strategies for ultra-central NSCLC.

2025 · Di Liu, Shuangyan Yang, et al. · Journal of Clinical Oncology

P1.16-18 Role of ERCC1/2 Single Nucleotide Polymorphism (SNP) on Treatment Response in Patients with Lung Cancer Undergoing Radiation Therapy

2018 · Y. Zhu, C. Jiang, et al. · Journal of Thoracic Oncology

P2.17-03 A Propensity-Matched Analysis of Neoadjuvant Chemoradiotherapy and Adjuvant Chemoradiotherapy for IIIA(N2) Non-Small Cell Lung Cancer

2018 · Y. Zhu, C. Jiang, et al. · Journal of Thoracic Oncology

P1.01-100 Concurrent Brain Radiotherapy and EGFR-TKI Have Better Survival Benefits in Patients with Brain Metastases from EGFR-Mutant NSCLC

2018 · Y. Zhu, Y. Chen, et al. · Journal of Thoracic Oncology

Works count: 15

Citation count: 92

H-index: 4

I10-index: 3